Health
Coronavirus vaccine from Oxford University is safe, can train immune system: early results – ABC News
The vaccine, called AZD1222 and under development by AstraZeneca and scientists at Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results.
A COVID-19 vaccine developed by scientists at Oxford University is safe and has produced an immune response in early-stage clinical trials in healthy volunteers, preliminary results say.
Key points:
- The experimental vaccine, called AZD1222, was administered to healthy adults aged 18-55 years with no history of COVID-19
- It did not prompt serious side effects and produced antibody and T-cell immune responses
- Several countries have signed agreements with AstraZeneca to pro…
Continue Reading